Decoy Therapeutics Inc. (DCOY) › Cash & EquivalentsDecoy Therapeutics Inc. (DCOY) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2017-12-31: $19.19M2018-12-31: $3.23M2019-12-31: $3.74M2020-12-31: $11.12M2021-12-31: $29.21M2022-12-31: $12.11M2023-12-31: $5.90M2024-12-31: $2.43M2025-12-31: $10.71M$10.71M2017-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$10.71M+339.9%2026-03-31Balance as of period end2024-12-31$2.43M-58.7%2026-03-31Balance as of period end2023-12-31$5.90M-51.3%2025-03-21Balance as of period end2022-12-31$12.11M-58.6%2024-03-22Balance as of period end2021-12-31$29.21M+162.8%2023-03-27Balance as of period end2020-12-31$11.12M+197.4%2022-03-25Balance as of period end2019-12-31$3.74M+15.8%2021-03-18Balance as of period end2018-12-31$3.23M-83.2%2020-03-23Balance as of period end2017-12-31$19.19M—2019-03-06Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)